Clustering in bioinformatics and drug discovery

Clustering in bioinformatics and drug discovery

by John D. MacCuish

Part of Chapman & Hall/CRC mathematical and computational biology series

Browse books you can read free on Readfeed

No club is reading this yet — be the first to start one

Start a club free
About
"This book presents an introduction to cluster analysis and algorithms in the context of drug discovery clustering applications. It provides the key to understanding applications in clustering large combinatorial libraries (in the millions of compounds) for compound acquisition, HTS results, 3D lead hopping, gene expression for toxicity studies, and protein reaction data. Bringing together common and emerging methods, the text covers topics peculiar to drug discovery data, such as asymmetric measures and asymmetric clustering algorithms as well as clustering ambiguity and its relation to fuzzy clustering and overlapping clustering algorithms"--Provided by publisher.

Discuss Clustering in bioinformatics and drug discovery with other readers

Join or start a book club for Clustering in bioinformatics and drug discovery on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Clustering in bioinformatics and drug discovery?

Sign up free on Readfeed, then browse public clubs or start your own club with Clustering in bioinformatics and drug discovery as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Clustering in bioinformatics and drug discovery with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Clustering in bioinformatics and drug discovery with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.